Equity Risk Sciences

Website

Equity Risk Sciences, Inc.

0 Investors
FinTech & Investment Research
NORTH KINGSTOWN, RI

Equity Risk Sciences, Inc. is a financial technology firm operating as an independent stock risk rating agency. The company utilizes data science, artificial intelligence, and proprietary algorithms to provide fiduciaries and institutional investors with quantitative, evidence-based ratings on stock price risk. Their services are designed to help investment professionals identify and avoid preventable losses through a scientific approach to risk management.

Products & Team

Fiduciary Stock Navigator™ (FSN™)

Fiduciary Risk RatingSeed

The Fiduciary Stock Navigator™ is a comprehensive rating system that assesses a stock's overall suitability for fiduciaries by integrating multiple dimensions of financial risk. It provides a single, easy-to-understand rating, such as 'A+', to indicate strong financials and low downside risk, consolidating complex data into an actionable metric.

Value Proposition

It helps fiduciaries meet their legal duty of care by providing objective, data-driven evidence to evaluate stock risk, thereby avoiding preventable investment losses and simplifying portfolio construction.

Pain Points

Customers face challenges in accurately quantifying downside risk for individual stocks, differentiating between market speculation and evidence-based analysis, and documenting their due diligence to meet strict fiduciary compliance standards.

Integrates multiple risk dimensions into a single suitability scoreBased on proprietary algorithms analyzing over 35 years of data from 15,000+ companiesProvides quantifiable metrics on both downside risk and upside opportunitySpecifically designed to aid with fiduciary compliance and due diligence
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
NORTH KINGSTOWN, RI
Primary headquarters

Funding History

Total Raised:
$565.0K
E

Equity Offering

May 2023
$20.0M
Target
Use of Proceeds
Includes $24K in early salary to director Harpin, up to $425K in future salaries to directors Mullaney and Harpin as funds permit, and approx. $1.5M (5-10% of raise) in estimated compensation to promoters and sales agents.
Progress
3%
Raised
$565.0K
Target
$20.0M
#000192381325000003